Literature DB >> 16467758

Serum copper in rural women taking combined oral contraceptive.

S Akhter1, A K Shamsuzzaman, M Banarjee, S A Seema, K Deb.   

Abstract

This prospective case-control study included 78 women between 15 to 45 years of age from rural area to see changes in serum copper level as a consequence of oral contraceptive use. Among the subjects, 34 women were included as controls because of not taking any form of hormonal contraceptives neither during the time of selection nor during one-year period prior to the study. Women in the control group were motivated to consume oral pill (Sukhi) for 3 consecutive cycles. At the 3(rd) month, 25 such women became available and henceforth included as cases on longitudinal basis. Another 44 women were randomly selected as cases on the basis of using combined oral contraceptives (Sukhi) for a duration of 4 months onwards. Considering different duration of oral contraceptive (OC) use, subjects were grouped as follows: Group I (n=34)--> controls, Group II (n=25)--> 3 months, Group III (n=17)--> 4 months - 2 years and Group IV (n=27)--> >2 years. Finally, 103 samples of blood (34 from controls and 69 from oral contraceptives users) were collected for estimation of Serum Copper (mgm/dl) by Atomic Absorption Spectrometry using UNICAM-AA Spectrometer. Mean+/-SD of Serum Copper significantly increased in all 3 contraceptive groups in comparison to controls (p<0.001). Further study including larger population from rural area was recommended to see correlation among serum copper and other trace elements with side effects of hormonal contraceptives. This preliminary study tried to explore the possibility of establishing biochemical monitoring of serum trace elements in OC users.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467758     DOI: 10.3329/mmj.v15i1.20

Source DB:  PubMed          Journal:  Mymensingh Med J        ISSN: 1022-4742


  2 in total

1.  Hepatic Effects of Estrogen on Plasma Distribution of Small Dense Low-Density Lipoprotein and Free Radical Production in Postmenopausal Women.

Authors:  Shota Nii; Koichi Shinohara; Hiroshi Matsushita; Yasuyuki Noguchi; Kazushi Watanabe; Akihiko Wakatsuki
Journal:  J Atheroscler Thromb       Date:  2016-02-22       Impact factor: 4.928

2.  Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.

Authors:  Marie Mawet; Catherine Maillard; Christine Klipping; Yvette Zimmerman; Jean-Michel Foidart; Herjan J T Coelingh Bennink
Journal:  Eur J Contracept Reprod Health Care       Date:  2015-07-27       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.